$Unusual Machines(UMAC.US)$
Unusual Machines Launches NDAA Compliant, Made in the USA Flight Controller for FPV Drones
Unusual Machines (NYSE American: UMAC) has launched the Rotor Riot Brave F7 Flight Controller, a Made in USA and NDAA compliant component for FPV drones. Key features include:
STM F722RET6 processor
Bosch accelerometer and barometer
16Mb built-in Blackbox Memory
Dimensions: 37mm x 37mm
Mounting Holes: 30mm x 30mm
The product is available for pre-sale at $49.50 (regular pri...

Morning Movers
Gapping up
$UnitedHealth(UNH.US)$ reported on Tuesday earnings and revenue for the fiscal Q2 2024 that beat consensus estimates. Q2 EPS stood at $6.80, above the analyst expectations of $6.67. Revenue for the quarter was $98.9 billion, slightly above the consensus estimate of $98.72 billion. The shares rose by 2.2% in premarket trading.
$Bank of America(BAC.US)$ After reporting second-quarter financial results t...

Jim Cramer was just asked if he would buy or sell Reddit $Reddit(RDDT.US)$ right now:
"oh, im going to buy Reddit"

$Reddit(RDDT.US)$ closed strong, up nearly 60% YTD with user traffic booming
Big winners: $Meta Platforms(META.US)$ +4.8% and $NVIDIA(NVDA.US)$ +3.2%
Meanwhile, $Tesla(TSLA.US)$ dipped -1.7%
Check out NASDAQ: $LOBO's +8.40% latest partnership news - poised for growth with Brazilian distributor! Zack's target: $5.

Follow Our Official Telegram Channel tynkrlab
The $Dow Jones Industrial Average(.DJI.US)$ closed at a new record high of 40,211.72, gaining 0.5%. The $S&P 500 Index(.SPX.US)$ rose 0.3%, and the $Nasdaq Composite Index(.IXIC.US)$ increased by 0.4%. This rally was driven by investor optimism about potential rate cuts and positive earnings reports from major banks.
Key Drivers
1. Federal Reserve’s Stance on Inflation:
• Event: Fed Chairman Jerome Powell...

$Kyverna Therapeutics(KYTX.US)$
Kyverna's KYV-101 Receives U.S. FDA RMAT Designation for KYV-101 in the Treatment of Patients With Refractory Stiff-Person Syndrome
Kyverna Therapeutics (KYTX) has received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA for KYV-101, its autologous CD19 CAR T-cell therapy, in treating refractory stiff-person syndrome. This designation, based on positive clinical outcomes in Germany, allows Kyverna to receive expert guidance on efficient ...

$Autonomix Medical(AMIX.US)$ the pull back seems like a littlw bit ../ ermmmmmmmm